[1]周正新,孙志涛,丁锷.骨蚀宁胶囊对激素性股骨头坏死患者凝血机制的影响[J].中医正骨,2013,25(03):31-34.
　ZHOU Zheng-xin*,SUN Zhi-tao,DING E..Effect of GUSHINING capsule on blood coagulation mechanism for patients with steroid-induced necrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):31-34.
点击复制

骨蚀宁胶囊对激素性股骨头坏死患者凝血机制的影响()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第25卷
期数:
2013年03期
页码:
31-34
栏目:
股骨头坏死
出版日期:
2013-03-20

文章信息/Info

Title:
Effect of GUSHINING capsule on blood coagulation mechanism for patients with steroid-induced necrosis of femoral head
作者:
周正新1; 孙志涛2; 丁锷1
1.安徽省中医院,安徽 合肥 230031;
2.广州中医药大学,广东 广州 510405
Author(s):
ZHOU Zheng-xin*; SUN Zhi-tao; DING E.
*Traditional Chinese Medical Hospital of Anhui Province,Hefei 230031,Anhui,China
关键词:
股骨头坏死 血液凝固 治疗; 临床研究性 骨蚀宁胶囊
Keywords:
Femur head necrosis;  Blood coagulation;  Therapies; investigational;  GUSHINING capsule
摘要:
目的:观察骨蚀宁胶囊对激素性股骨头坏死患者凝血机制的影响。方法:将纳入研究的62例激素性股骨头坏死患者随机分为2组,骨蚀宁组32例,仙灵骨葆组30例。分别采用口服骨蚀宁胶囊和仙灵骨葆胶囊治疗。分别于治疗前和治疗12个月后抽血测定并比较2组患者的血浆血栓素B2、6-酮-前列腺素F1α、P选择素和血栓调节蛋白含量。结果:治疗前骨蚀宁组和仙灵骨葆组患者的血浆血栓素B2、P选择素、血栓调节蛋白和6-酮-前列腺素F1α含量比较,差异均无统计学意义[(27.95±7.08)ng·L-1,(28.99±4.43)ng·L-1,t=3.473,P=0.247;(11.76±2.11)μg·L-1,(11.43±1.26)μg·L-1,t=1.402,P=0.183;(7.15±1.74)μg·L-1,(7.84±0.91)μg·L-1,t=0.762,P=0.105;(52.35±13.61)ng·L-1,(44.27±7.54)ng·L-1,t=24.294,P=0.619]。治疗后2组患者血浆血栓素B2、P选择素和血栓调节蛋白的含量均下降[(16.19±4.88)ng·L-1,(20.90±4.09)ng·L-1;(6.40±1.81)μg·L-1,(7.65±1.01)μg·L-1;(3.55±1.28)μg·L-1,(6.21±1.62)μg·L-1],但骨蚀宁组下降更明显[(11.76±2.20)ng·L-1,(8.09±0.34)ng·L-1,t=6.824,P=0.000;(5.36±0.30)μg·L-1,(3.78±0.25)μg·L-1,t=4.215,P=0.000;(3.60±0.46)μg·L-1,(1.63±0.71)μg·L-1,t=4.162,P=0.000]; 治疗后骨蚀宁组和仙灵骨葆组患者的血浆6-酮-前列腺素F1α含量均上升[(161.04±19.46)ng·L-1,(119.80±14.21)ng·L-1],但骨蚀宁组上升更明显[(108.69±5.85)ng·L-1,(75.53±6.67)ng·L-1; t=39.203,P=0.000]。结论:骨蚀宁胶囊能缓解激素引起的血管内皮损害,抑制血小板聚集及预防血黏度增高,改善激素性股骨头坏死患者股骨头微循环和凝血功能,其作用优于仙灵骨葆胶囊。
Abstract:
Objective:To observe the effect of GUSHINING capsule on blood coagulation mechanism for patients with steroid-induced necrosis of femoral head(SNFH).Methods:Sixty-two SNFH patients were included into the study and were randomly divided into 2 groups,32 patients were administrated with GUSHINING capsule(GUSHINING group),while the others were administrated with XIANLINGGUBAO capsule(XIANLINGGUBAO group).The contents of thromboxane B2(TXB2),6-keto-prostaglandin F1α(6-keto-PGF1α),P-selectin and thrombomodulin(TM)in blood plasma were detected and compared between the 2 groups before the treatment and 12 months after the treatment respectively.Results:There were no statistical differences in contents of TXB2,P-selectin,TM and 6-keto-PGF1α,in blood plasma between the 2 groups before the treatment[(27.95±7.08)ng·L-1,(28.99±4.43)ng·L-1,t=3.473,P=0.247;(11.76±2.11)μg·L-1,(11.43±1.26)μg·L-1,t=1.402,P=0.183;(7.15±1.74)μg·L-1,(7.84±0.91)μg·L-1,t=0.762,P=0.105;(52.35±13.61)ng·L-1,(44.27±7.54)ng·L-1,t=24.294,P=0.619].The contents of TXB2,P-selectin and TM in blood plasma of the 2 groups declined after the treatment[(16.19±4.88)ng·L-1,(20.90±4.09)ng·L-1;(6.40±1.81)μg·L-1,(7.65±1.01)μg·L-1;(3.55±1.28)μg·L-1,(6.21±1.62)μg·L-1],and there was a bigger decline in GUSHINING group compared to XIANLINGGUBAO group[(11.76±2.20)ng·L-1,(8.09±0.34)ng·L-1,t=6.824,P=0.000;(5.36±0.30)μg·L-1,(3.78±0.25)μg·L-1,t=4.215,P=0.000;(3.60±0.46)μg·L-1,(1.63±0.71)μg·L-1,t=4.162,P=0.000]; while the plasma 6-keto-PGF1α contents for the 2 groups increased after the treatment[(161.04±19.46)ng·L-1,(119.80±14.21)ng·L-1],and there was a bigger increase in GUSHINING group compared to XIANLINGGUBAO group[(108.69±5.85)ng·L-1,(75.53±6.67)ng·L-1; t=39.203,P=0.000].Conclusion:GUSHINING capsule can improve microcirculation and blood coagulation functions of femoral head for SNFH patients through relieving the steroid-induced injuries of vascular endothelium,prohibiting platelet aggregation and preventing the increase of blood viscosity.Furthermore,the effect of GUSHINING capsule is better than that of XIANLINGGUBAO capsule.

参考文献/References:

[1] Ficat RP.Idiopathic bone necrosis of the femoral head.Early diagnosis and treatment[J].J Bone Joint Surg Br,1985,67(1):3-9.
[2] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社,1994:193.
[3] 周正新,刘安平,王峰,等.丁锷论治股骨头缺血性坏死的学术特点[J].中医药临床杂志,2007,19(3):209-210.
[4] 龚梅芳,徐传毅,邹季,等.活血健骨汤对兔缺血性股骨头坏死TXB2和6-Keto-PGF1α的作用[J].中国微循环,2001,5(2):123.
[5] 齐振熙,曹阳.不同治法对激素性股骨头坏死血液流变学及血脂影响的实验研究[J].中国中医骨伤科杂志,2001,9(5):30-32.
[6] 肖正权.健骨颗粒治疗无菌性股骨头坏死120例临床观察[J].中医药学报,2002,30(4):33.
[7] 左萍萍,吴业华,李学坤,等.新骨生胶囊治疗股骨头坏死的药理研究[J].中国康复理论与实验,2002,8(1):11-12.
[8] 肖鲁伟,董培建,赵万军,等.激素诱导的股骨头坏死与肾阳虚证之间的关系[J].中医正骨,1998,10(4):3-4.
[9] 洪加源,许书亮,阮景绰,等.复元散对激素性股骨头坏死脂代谢的影响[J].中医正骨,2001,13(4):6-8.
[10] 袁浩,方斌,何伟,等.生脉成骨胶囊治疗激素性股骨头坏死的实验研究[J].中医正骨,1999,11(8):3-4.
[11] 周正新,刘安平,周章武,等.辨证应用骨蚀宁Ⅰ号、Ⅱ号方治疗股骨头缺血性坏死76例临床观察[J].中医药临床杂志,2011,23(1):38-39.
[12] 孙志涛,周正新,牛维,等.骨蚀宁胶囊对激素性股骨头坏死模型兔凝血机制的影响[J].中国组织工程研究,2012,16(7):1295-1298.
[13] Kyrle PA,Hron G,Eichinger S,et al.Circulating P-selectin and the risk of recurrent venous thromboembolism[J].Thromb Haemost,2007,97(6):880-883.
[14] Chung T,Connor D,Joseph J,et al.Platelet activation in acute pulmonary embolism[J].J Thromb Haemost,2007,5(5):918-924.
[15] Ay C,Jungbauer LV,Sailer T,et al.High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant[J].Clin Chem,2007,53(7):1235-1243.
[16] Esmon NL.Thrombomodulin[J].Semin Thromb Hemost,1987,13(4):454-463.

备注/Memo

备注/Memo:
基金项目:安徽省卫生厅课题(2009ZY15)
通讯作者:孙志涛 E-mail:harrison0611@163.com
更新日期/Last Update: 2013-03-20